Viking Therapeutics, Inc. (VKTX)
34.26
-0.69
(-1.97%)
USD |
NASDAQ |
Apr 10, 16:00
34.20
-0.06
(-0.18%)
After-Hours: 20:00
Viking Therapeutics Shareholders Equity (Quarterly) : 639.06M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Eli Lilly & Co. | 26.54B |
| Amgen, Inc. | 8.658B |
| Pfizer Inc. | 86.48B |
| Structure Therapeutics, Inc. | 1.516B |
| Hims & Hers Health, Inc. | 540.93M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 715.73M |
| Total Liabilities (Quarterly) | 76.67M |
| Debt to Equity Ratio | 0.0002 |
| Current Ratio | 9.334 |
| Net Debt Paydown Yield | 0.01% |